Xencor, Inc.
Heterodimeric antibodies that bind CD3 and CD38
Last updated:
Abstract:
The present invention is directed to heterodimeric antibodies that bind CD3 and CD38.
Status:
Grant
Type:
Utility
Filling date:
22 Oct 2019
Issue date:
7 Jun 2022